Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 28, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 30, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-197734
Filed / recorded
Apr 30, 2026, 8:57 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
HCA Healthcare, Inc.
Issuer CIK
860730
Ticker
HCA
Reporting person
John Chidsey
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Apr 28, 2026
Transaction code
A
Shares / units
809
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,305
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.